Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
YNC Medical appears to be a healthcare-focused commercial partner and medical-device company operating in China, rather than a drug-development biotech. Publicly available information indicates that it has worked to introduce and commercialize advanced medical products and technologies in China, with a particular emphasis on intradermal delivery systems. The clearest externally documented activity is its role as NanoPass's partner in the China medical market, supporting promotion, physician training, and academic outreach for the MicronJet intradermal delivery platform. Based on the available evidence, YNC Medical is best characterized as a medtech commercialization and market-development company rather than a therapeutics pipeline company. There is insufficient reliable public evidence of an internal drug pipeline, proprietary therapeutic targets, or clinical-stage pharmaceutical assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on YNC Medical.